Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Piper Sandler Analyst Says

Privia Health Group (NASDAQ:PRVA) had its target price hoisted by equities researchers at Piper Sandler from $25.00 to $40.00 in a report released on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Piper Sandler’s target price would indicate a potential upside of 60.19% from the company’s previous close.

Several other research analysts also recently weighed in on the stock. Barclays lifted their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Truist Financial raised their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities restated a “market outperform” rating and set a $26.00 price target on shares of Privia Health Group in a report on Friday, February 14th. JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Finally, Macquarie began coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. One research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $26.47.

Privia Health Group Price Performance

Privia Health Group stock opened at $24.97 on Friday. The firm’s 50 day simple moving average is $22.40 and its 200-day simple moving average is $20.60. The company has a market cap of $3.00 billion, a P/E ratio of 249.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Institutional Trading of Privia Health Group

Institutional investors have recently added to or reduced their stakes in the business. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares during the period. EverSource Wealth Advisors LLC raised its position in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after purchasing an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group in the fourth quarter valued at approximately $51,000. Quarry LP raised its position in shares of Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares during the period. Finally, KBC Group NV raised its position in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after purchasing an additional 871 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.